Hemolink™-Induced Effects on Intestinal Motor Function and Attenuation of These Effects by Selected Agents

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 26, Issue 42130, 1998, Pages 529-548

  Wong, Lawrence T ^a   er, Song S ^a   Ning, Jing ^a   Christoff, Borislav ^a   Lou Carmichael, F J ^a  

^a Hemosol Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLYCERYL TRINITRATE; GLYCOPYRRONIUM BROMIDE; HEMOGLOBIN; MORPHINE; N(G) NITROARGININE METHYL ESTER; NIFEDIPINE; NITRIC OXIDE; RAFFINOSE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; NARCOTIC ANALGESIC AGENT; O RAFFINOSE CROSS LINKED HUMAN HEMOGLOBIN; O-RAFFINOSE CROSS-LINKED HUMAN HEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; ESOPHAGUS MOTILITY; HEART RATE; INTESTINE MOTILITY; JEJUNUM; MALE; MOTOR PERFORMANCE; NONHUMAN; OXYGEN TRANSPORT; RAT; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE TONE; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; GASTROINTESTINAL MOTILITY; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PHYSIOLOGY; WISTAR RAT;

ANIMALIA;

BLOOD; HEMODYNAMICS; HEMOGLOBIN; NEUROPHYSIOLOGY;

HEMOLINK; INTESTINAL MOTOR FUNCTION; NITRIC OXIDE EFFECTS; RAT MODEL;

BLOOD SUBSTITUTES;

ANALGESICS, OPIOID; ANIMALS; ARGININE; GASTROINTESTINAL MOTILITY; GLYCOPYRROLATE; HEMODYNAMIC PROCESSES; HEMOGLOBINS; HUMANS; INFUSIONS, INTRAVENOUS; JEJUNUM; MALE; MORPHINE; NIFEDIPINE; NITROGLYCERIN; RAFFINOSE; RATS; RATS, WISTAR;

EID: 0031593486     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.3109/10731199809117473     Document Type: Article

References (26)

1. Xue SW, Paterson W, Diamant N, Miller D, Christoff B, Wong L. Effect of an o-raffinose cross-linked hemoglobin product on esophageal and lower esophageal sphincter motor function. Abstract. Annual Meeting of American Gastroenterological Association and American Association for the Study of Liver Diseases May, 1997; 11 – 14
2. Chakder S, Rosenthal GJ, Rattan S. In vivo and in vitro influence of human recombinant hemoglobin on esophageal function. Am J Physiol 1995; 268: G443 – G450
3. Conklin JL, Murray J, Ledlow A, Clark E, Hayek B, Picken H, Rosenthal G. Effects of recombinant human hemoglobin on motor functions of the opossum esophagus. J Pharmacol Expt Therap 1995; 273: 762 – 767
4. Przybelski RJ, Daily EK, Kisicki JC, Mattia-Goldberg C, Bounds MJ, Colbum WA. Phase I study of the safety and pharmacological effects of diaspirin cross-linked hemoglobin solution. Crit Care Med 1996; 24: 1993 – 2000
5. Murray J A, Ledlow A, Launspach J, Evans D, Loveday M, Conklin JL. The effects of recombinant human hemoglobin on esophageal motor function in humans. Gastroenterology 1995; 109: 1241 – 1248
6. Preiksaitis H G, Tremblay L, Diamant NE. Nitric oxide mediates inhibitory nerve effects in human esophagus and lower esophageal sphincter. Dig Dis Sci 1994; 39: 770 – 775
7. Murray J A, Du C, Ledlow A. Is nitric oxide the noncholinergic, nonadrenergic neurotransmitter responsible for lower esophageal sphincter relaxation?. Am J Physiol 1992; 263: G97 – G101
8. McKirdy H C, McKirdy M L, Lewis M J, Marshall RW. Evidence for involvement of nitric oxide in the non-adrenergic non-cholinergic (NANC) relaxation of human lower esophageal sphincter muscle strips. Exp Physiol 1992; 77: 509 – 511
9. Li CG, Rand MJ. Nitric oxide and vasoactive intestine polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur J Pharmacol 1990; 303 – 309; 191
10. Irie K, Muraki T, Furukawa K, Nomoto T. L-NG-nitro-arginine inhibits nicotine-induced relaxation of isolated rat duodenum. Eur J Pharmacol 1991; 202: 285 – 288
11. Kanada S, Hata F, Suthamnatpong N, Machara T, Sigh T, Takeuchi T, Yagasaki O. Key role of nitric oxide and cyclic GMP in nonadrenergic and noncholinergic inhibition in rat ileum. Eur J Pharmacol 1992; 216: 287 – 292
12. Hata F, Sign T, Kanada A, Yamano N, Kataoka T, Takeuchi T, Yagasaki O. Essential role of nitric oxide in descending inhibition in the rat proximal colon. Biochem Biophys Res Comm 1990; 172: 1400 – 1406
13. Desai KM, Sessa WC, Vane JR. Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid. Nature 1991; 351: 477 – 479
14. Gustafsson LE, Wiklund CU, Wiklund NP, Persson MG, Moncada S. Modulation of autonomic neuroeffector transmission by nitric oxide in guinea-pig ileum. Biochem Biophys Res Comm 1990; 173: 106 – 110
15. Boeckxstaens GE, Pelckmans PA, Bult H, De Man JG, Herman AG, Van Maercke YM. Non-adrenergic non-cholinergic relaxation mediated by nitric oxide in the canine ileocolonic junction. Eur J Pharmacol 1990; 190: 239 – 246
16. Toda N, Baba H, Okamura T. Role of nitric oxide as non-adrenergic, non-cholinergic nerve-mediated relaxation in dog duodenal longitudinal muscle strips. Jap J Pharmacol 1990; 53: 281 – 284
17. Dalziel HH, Thornbury KD, Ward SM, Sanders KM. Involvement of nitric oxide synthetic pathway in inhibitory junction potentials in canine proximal colon. Am J Physiol 1991; 260: G789 – G792
18. Calignano A, Whittle BJR, Rosa Di M, Moncada S. Involvement of endogenous nitric oxide in the regulation of rat intestinal motility in vivo. Eur J Pharmacol 1992; 229: 273 – 276
19. Adamson GA, Bonaventura BJ, Er SS, Jones RT, Langlois SF, MacDonald ID, Moore C, Pliura DH, Rydall JR, Wicks DG, Wiffen DE, Wojciechowski PW, Wong LT. Product characterization and clinical evaluation of Hemolink, an o-raffinose crosslinked hemoglobin based blood substitute. Red Blood Cell Substitutes:Basic Principles and Clinical Applications, Rudolph, Rabinovici, Feuernstein. Marcel Dekker Inc., New York, NY 1997, In Press
20. Jaffe JH, Martin WR. Opioid analgesics and antagonists. Goodman and Gilman's The Pharmacological Basis of Therapeutics, Gilman, Rail, Nies, Taylor. McGraw-Hill, Inc. 1993; 485
21. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 12231 – 12234
22. Murad F. Drugs used for the treatment of agina: organic nitrates, calcium-channel blockers, and p-adrenergic antagonists. Goodman and Gilman's The Pharmacological Basis of Therapeutics, Gilman, Rail, Nies, Taylor. McGraw-Hill, Inc. 1993; 764
23. Brown JH. Atropine, scopolamine and related antimuscarinic drugs. Goodman and Gilman's The Pharmacological Basis of Therapeutics, Gilman, Rail, Nies, Taylor. McGraw-Hill, Inc. 1995; 150
24. Pliura DH, Wong LT, Er SS. Selective crosslinking of hemoglobin by oxidized, ring-opened saccharides. US Pat. July 2, 1996; 5: 352, 532
25. Schultz SC, Grady B, Cole F, Hamilton I, Burhop Malcolm Kand DS. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med 1993; 122: 301 – 308
26. Przybelski RJ. Administration of low dose hemoglobin to increase perfusion. US Patent 1996; 5: 464, 510